News
A once-weekly dose of tirzepatide (Mounjaro) can lead to significant, sustained weight loss for up to 3 years in adults with ...
Drugmaker Eli Lilly said that in Phase 3 studies of over 550 adults, their oral GLP-1 pill, orforglipron, could reduce ...
People diagnosed with type 2 diabetes might benefit soon from Eli Lilly's new orforglipron weight loss drug following its ...
Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable ...
But this one, for Lilly’s first diabetes and weight-loss pill based on the GLP-1 hormone, was particularly fraught. Days ...
Medical conditions can limit which weight loss pills work safely for you. For example, you should avoid phentermine if you ...
A diverse range of medical specialists offer unique expertise for obesity treatment. “Endocrinologists, bariatricians, obesity specialists and psychiatrists can prescribe weight loss medication,” ...
The Associated Press on MSN13d
The skyrocketing cost of weight-loss drugs has state Medicaid programs looking for a solutionStates that do provide coverage have tried to manage costs by putting prescribing limits on the GLP-1s. There’s also some ...
Evening Standard on MSN10d
Watchdog cracks down on ads for prescription-only weight-loss drugsAdvertising weight-loss prescription-only medicines to the public is against the law (Alamy/PA) The advertising watchdog has ...
The advertising watchdog has launched a crackdown on the advertising of prescription-only weight-loss medication, warning anyone doing so is breaking the law. The Advertising Standards Authority (ASA) ...
The Advertising Standards Authority (ASA) discovered about 1,800 unique paid-for weight-loss ads during a search in January that appeared to be promoting prescription-only medications (POMs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results